Fundació Lluita contra les Infeccions STI/NTD team in collaboration w/ London School of Hygiene & Tropical Medicine just published a case series of #mpox in people with advanced #hiv infeccion. Congratulations Andrea Alemany Oriol Mitjà Michael Marks and team for this amazing work!

‘Horrific’ form of mpox found to affect people with advanced HIV | Monkeypox | The Guardian theguardian.com/world/2023/feb…

There is a concern that advanced HIV could predispose to more severe #mpox. Presented at #CROI2023, a case series describes the clinical characteristics and outcomes of mpox in people with HIV and low CD4 cell counts (CD4 <350 cells per mm3): hubs.li/Q01D2X4q0

Our latest paper is out in The Lancet and reveals the severe implications of #mpox in people with advanced #HIV infection. See the details in this thread by our colleague Andrea Alemany

Participar a l’estudi #REMAIN té premi! La #recerca té com a objectiu conèixer els factors de risc de la #mpox i nivell d’eficàcia de la vacuna. 😍 Nit a l'Hotel Axel Hotels 😍 Sopar per a 6 persones nikkei103 Vols saber-ne més?👇 bit.ly/3mfuSjX Oriol Mitjà

Sóc part d'un equip que promou el desenvolupament social amb intel·ligència, paciència, vitalitat, i amor pels altres.🩺🔬 #Trepab Amb el finançament de la Unió Europea. European Research Council (ERC) curetrep.org Fundació Lluita contra les Infeccions

#ECCMID2023 Year in ID - shout out for our paper The Lancet bit.ly/40fzvc1 on severe #MPOX in advanced HIV which showed high rates of complications & mortality

Our latest #mpox study shorturl.at/fhCK8 provides comprehensive assessment of immune responses amongst people with and without #HIV at time of infection through to six months. Antibody titres at baseline were associated with time to viral clearance 1/N

Our series The Lancet Reg Health-Europe on STI control on the continent covering a) epidemiology shorturl.at/bvFGZ b) treatment shorturl.at/kmnsG c) prevention shorturl.at/fqANQ & d) screening shorturl.at/efnqW Phenomenal team effort co-ordinated by Oriol Mitjà

Today, we are launching our Series on 'Sexually Transmitted Infections' at IUSTI Europe conference in Malta. #IUSTIEurope2023 Read all the 4 papers of the Series here 👇 thelancet.com/series/europe-…

Must read: free access & features, in a fab cast, Oscar-winning Teymur Noori & Jean-michel Molina! "We examine successful vax campaigns against HBV & HPV, ongoing development of vax for chlamydia, syphilis, HSV & gonorrhoea, and challenges in HIV vax research" ncbi.nlm.nih.gov/pmc/articles/P…

🎓 Felicitats a la Dra. Andrea Alemany per la defensa de la seva tesi doctoral. "Passive immunotherapy for the treatment and prevention of COVID-19" sota la direcció del Dr. Oriol Mitjà 🌟 La teva dedicació i esforç han donat els seus fruits. Moltes felicitats! #infeccions

Delighted our #mpox work in The Lancet Microbe shorturl.at/pXZNU We nested study immune responses in our viral dynamics cohort shorturl.at/IVaYm At diagnosis IgA responses broader than IgG. Both humoral & T-cell responses were similar in individuals with & without HIV 1/6

🎬 Our newest short film takes us to Brazil 🇧🇷, Sri Lanka 🇱🇰, and Thailand 🇹🇭 to show the devastating impact #dengue outbreaks are having across the world. 🦟🌍#beatNTDs #GlobalHealth Watch now! 👉 bit.ly/denguefilm

Dengue is a major – and growing — threat to global health. Thank you Drugs for Neglected Diseases initiative for providing this powerful video to kick off our session "The Path Towards a Treatment for Dengue: Endemic Country Leadership, Progress and Perspectives" #TropMed24 youtube.com/watch?v=imS6Sp…